182 related articles for article (PubMed ID: 8913266)
41. Limited proteolysis of tubulin and the localization of the binding site for colchicine.
Serrano L; Avila J; Maccioni RB
J Biol Chem; 1984 May; 259(10):6607-11. PubMed ID: 6725263
[TBL] [Abstract][Full Text] [Related]
42. Differences in the binding properties of vinca alkaloids and colchicine to tubulin by varying protein sources and methodology.
Hans FO; Dickerson RM; Wilson L; Owellen RJ
Biochem Pharmacol; 1978 Jan; 27(1):71-6. PubMed ID: 563724
[No Abstract] [Full Text] [Related]
43. The binding of vinca domain agents to tubulin: structural and biochemical studies.
Cormier A; Knossow M; Wang C; Gigant B
Methods Cell Biol; 2010; 95():373-90. PubMed ID: 20466145
[TBL] [Abstract][Full Text] [Related]
44. Tubulin inhibitors: a patent survey.
Nepali K; Ojha R; Sharma S; Bedi PM; Dhar KL
Recent Pat Anticancer Drug Discov; 2014 May; 9(2):176-220. PubMed ID: 23746164
[TBL] [Abstract][Full Text] [Related]
45. The interaction of the B-ring of colchicine with alpha-tubulin: a novel footprinting approach.
Chaudhuri AR; Seetharamalu P; Schwarz PM; Hausheer FH; Ludueña RF
J Mol Biol; 2000 Nov; 303(5):679-92. PubMed ID: 11061968
[TBL] [Abstract][Full Text] [Related]
46. Fluorescence spectroscopic methods to analyze drug-tubulin interactions.
Bhattacharyya B; Kapoor S; Panda D
Methods Cell Biol; 2010; 95():301-29. PubMed ID: 20466142
[TBL] [Abstract][Full Text] [Related]
47. The interaction of spongistatin 1 with tubulin.
Bai R; Smith AB; Pettit GR; Hamel E
Arch Biochem Biophys; 2022 Sep; 727():109296. PubMed ID: 35594923
[TBL] [Abstract][Full Text] [Related]
48. Action of drugs on microtubules.
Wilson L
Life Sci; 1975 Aug; 17(3):303-9. PubMed ID: 1099380
[No Abstract] [Full Text] [Related]
49. Conformational changes in tubulin upon binding cryptophycin-52 reveal its mechanism of action.
Eren E; Watts NR; Sackett DL; Wingfield PT
J Biol Chem; 2021 Oct; 297(4):101138. PubMed ID: 34461087
[TBL] [Abstract][Full Text] [Related]
50. Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains.
Naaz F; Haider MR; Shafi S; Yar MS
Eur J Med Chem; 2019 Jun; 171():310-331. PubMed ID: 30953881
[TBL] [Abstract][Full Text] [Related]
51. Specific Vinca alkaloid-binding polypeptides identified in calf brain by photoaffinity labeling.
Safa AR; Felsted RL
J Biol Chem; 1987 Jan; 262(3):1261-7. PubMed ID: 3543001
[TBL] [Abstract][Full Text] [Related]
52. The cryptophycin-tubulin ring structure indicates two points of curvature in the tubulin dimer.
Watts NR; Cheng N; West W; Steven AC; Sackett DL
Biochemistry; 2002 Oct; 41(42):12662-9. PubMed ID: 12379108
[TBL] [Abstract][Full Text] [Related]
53. The effect of TN-16 on the alkylation of tubulin.
Roach MC; Luduena RF
Biochem Biophys Res Commun; 1985 May; 129(1):200-5. PubMed ID: 4004874
[TBL] [Abstract][Full Text] [Related]
54. Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site.
Matthew S; Chen QY; Ratnayake R; Fermaintt CS; Lucena-Agell D; Bonato F; Prota AE; Lim ST; Wang X; Díaz JF; Risinger AL; Paul VJ; Oliva MÁ; Luesch H
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619102
[TBL] [Abstract][Full Text] [Related]
55. Direct photoaffinity labeling of tubulin with colchicine.
Wolff J; Knipling L; Cahnmann HJ; Palumbo G
Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2820-4. PubMed ID: 2011590
[TBL] [Abstract][Full Text] [Related]
56. Interaction of bovine brain tubulin with the 4(1H)-pyrizinone derivative IKP104, an antimitotic drug with a complex set of effects on the conformational stability of the tubulin molecule.
Luduena RF; Roach MC; Prasad V; Chaudhuri AR; Tomita I; Mizuhashi F; Murata K
Biochemistry; 1995 Dec; 34(48):15751-9. PubMed ID: 7495806
[TBL] [Abstract][Full Text] [Related]
57. Interaction of ustiloxin A with bovine brain tubulin.
Ludueńa RF; Roach MC; Prasad V; Banerjee M; Koiso Y; Li Y; Iwasaki S
Biochem Pharmacol; 1994 Apr; 47(9):1593-9. PubMed ID: 8185673
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the interaction of TZT-1027, a potent antitumor agent, with tubulin.
Natsume T; Watanabe J; Tamaoki S; Fujio N; Miyasaka K; Kobayashi M
Jpn J Cancer Res; 2000 Jul; 91(7):737-47. PubMed ID: 10920282
[TBL] [Abstract][Full Text] [Related]
59. Cellular uptake of a novel cytotoxic agent, cryptophycin-52, by human THP-1 leukemia cells and H-125 lung tumor cells.
Chen BD; Nakeff A; Valeriote F
Int J Cancer; 1998 Sep; 77(6):869-73. PubMed ID: 9714056
[TBL] [Abstract][Full Text] [Related]
60. In vitro effect of cryptophycin 52 on microtubule assembly and tubulin: molecular modeling of the mechanism of action of a new antimitotic drug.
Barbier P; Gregoire C; Devred F; Sarrazin M; Peyrot V
Biochemistry; 2001 Nov; 40(45):13510-9. PubMed ID: 11695898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
